C667T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene and susceptibility to myocardial infarction: A systematic review and meta-analysis.

[1]  S. Aref,et al.  Association of Hemostatic Gene Polymorphisms With Early-Onset Ischemic Heart Disease in Egyptian Patients , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  Xiang Gao,et al.  Association between 5,10-Methylenetetrahydrofolate Reductase C677T Gene Polymorphism and Risk of Ischemic Stroke: A Meta-analysis. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[3]  Xianjun Wang,et al.  Methylenetetrahydrofolate reductase gene polymorphism in endometrial cancer: A systematic review and meta-analysis. , 2015, Taiwanese journal of obstetrics & gynecology.

[4]  R. Nicoll,et al.  Cardiovascular calcification and bone: a comparison of the effects of dietary and serum antioxidants , 2015 .

[5]  M. Nasiri,et al.  Association of Methylenetetrahydrofolate Reductase (MTHFR) Gene C677T and A1298C Polymorphisms with Myocardial Infarction from North of Fars Province , 2014 .

[6]  Hamdia. Ezzat,et al.  Prevalence of thrombophilic gene polymorphisms (FVL G1691A and MTHFR C677T) in patients with myocardial infarction , 2014 .

[7]  M. Ulaşlı,et al.  Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey , 2014, Molecular Biology Reports.

[8]  B. Nsiri,et al.  Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with myocardial infarction in Tunisian young patients , 2014, Comparative Clinical Pathology.

[9]  O. Shaker,et al.  Association of Genetic Variants of MTHFR, ENPP1, and ADIPOQ with Myocardial Infarction in Egyptian Patients , 2013, Cell Biochemistry and Biophysics.

[10]  K. Blennow,et al.  The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism , 2013, Heart.

[11]  L. Weinehall,et al.  Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population , 2013, Lipids in Health and Disease.

[12]  Ying Luo,et al.  Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for Down syndrome offspring: a meta-analysis. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[13]  T. Yoneda,et al.  Involvement of toll-like receptor 2 and 4 in association between dyslipidemia and osteoclast differentiation in apolipoprotein E deficient rat periodontium , 2013, Lipids in Health and Disease.

[14]  M. Lelonek,et al.  Genetic Polymorphisms and the Risk of Myocardial Infarction in Patients Under 45 Years of Age , 2012, Biochemical Genetics.

[15]  D. Noto,et al.  Prothrombotic gene variants as risk factors of acute myocardial infarction in young women , 2012, Journal of Translational Medicine.

[16]  Yuan-hong Shi,et al.  Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and risk of myocardial infarction: need for clarification of data in a recent meta-analysis. , 2012, Archives of medical research.

[17]  E. Onrat,et al.  Prevalence of myocardial infarction polymorphisms in Afyonkarahisar, Western Turkey , 2012, Molecular Biology Reports.

[18]  Rongrong Yang,et al.  Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: An update by meta-analysis , 2012, Molecular and Cellular Endocrinology.

[19]  E. Nicolaides,et al.  Homocysteine levels and MTHFR polymorphisms in young patients with acute myocardial infarction: a case control study. , 2012, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[20]  J. Ahluwalia,et al.  Prothrombotic gene polymorphisms and plasma factors in young north Indian survivors of acute myocardial infarction , 2012, Journal of Thrombosis and Thrombolysis.

[21]  I. Czuriga,et al.  Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study. , 2012, Thrombosis research.

[22]  Amit N. Patel,et al.  Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA , 2012, Journal of Translational Medicine.

[23]  K. Goud,et al.  Sequence variation of the methylene tetrahydrofolate reductase gene (677C>T and 1298 A>C) and traditional risk factors in a South Indian population. , 2011, Genetic testing and molecular biomarkers.

[24]  F. Celep,et al.  MTHFR C677T polymorphism and its relationship to myocardial infarction in the Eastern Black Sea region of Turkey. , 2011, Archives of medical research.

[25]  Qin Yang,et al.  Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls. , 2011, Archives of medical research.

[26]  J. Ruan,et al.  MTHFR 677C>T and 1298A>C polymorphisms and male infertility risk: a meta-analysis , 2011, Molecular Biology Reports.

[27]  S. Hammami,et al.  Association of the C677T MTHFR Polymorphism With Homocysteine, Ox-LDL Levels, and Thiolactonase Activities in the Severity of Coronary Syndrome , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[28]  A. Majluf-Cruz,et al.  C677T polymorphism of the 5,10 MTHFR gene in young Mexican subjects with ST-elevation myocardial infarction. , 2010, Archives of medical research.

[29]  Y. Lee,et al.  Associations between the C677T and A1298C Polymorphisms of MTHFR and the Efficacy and Toxicity of Methotrexate in Rheumatoid Arthritis , 2010, Clinical drug investigation.

[30]  J. Perunicić,et al.  Incidence of Hyperhomocysteinemia and Mthfr C677T Polymorphism Among Young Patients with Acute Myocardial Infarction , 2009 .

[31]  G. Avvisati,et al.  Methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism and late infarct-related coronary artery patency after thrombolysis , 2009, Journal of Thrombosis and Thrombolysis.

[32]  O. Ayyıldız,et al.  Thrombophilia in young patients with acute myocardial infarction. , 2008, Saudi medical journal.

[33]  G. Tsongalis,et al.  MTHFR Gene polymorphisms, B-vitamins and hyperhomocystinemia in young and middle-aged acute myocardial infarction patients. , 2007, Experimental and molecular pathology.

[34]  K. Wulff,et al.  Common polymorphisms and cardiovascular factors in patients with myocardial infarction of Costa Rica. , 2014, Revista de biologia tropical.

[35]  H. Yoshida,et al.  Assessment of genetic risk for myocardial infarction , 2006, Thrombosis and Haemostasis.

[36]  Tasneem Fatima,et al.  Lack of association of methylenetetrahydrofolate reductase 677C>T mutation with coronary artery disease in a Pakistani population , 2005, Journal of molecular and genetic medicine : an international journal of biomedical research.

[37]  S. Tufik,et al.  Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[38]  M. Ragab,et al.  Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects , 2004, International journal of medical sciences.

[39]  G. Tsongalis,et al.  Prevalence of MTHFR gene polymorphisms (C677T and A1298C) among Tamilians. , 2004, Experimental and molecular pathology.

[40]  D. Mohanty,et al.  Combination of thrombophilia markers in acute myocardial infarction of the young. , 2004, Indian journal of medical sciences.

[41]  Y. Kokubo,et al.  An association analysis between genetic polymorphisms of matrix metalloproteinase‐3 and methylenetetrahydrofolate reductase and myocardial infarction in Japanese , 2004, Journal of thrombosis and haemostasis : JTH.

[42]  A. Algra,et al.  Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C → T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels , 2004, Journal of thrombosis and haemostasis : JTH.

[43]  R. Pegoraro,et al.  Risk factors and methylenetetrahydrofolate reductase gene polymorphisms in a young South African Indian-based population with acute myocardial infarction : cardiovascular topics , 2003 .

[44]  R. Pegoraro,et al.  Risk factors and methylenetetrahydrofolate reductase gene polymorphisms in a young South African Indian-based population with acute myocardial infarction. , 2003, Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners.

[45]  M. Margaglione,et al.  No Evidence of Association Between Prothrombotic Gene Polymorphisms and the Development of Acute Myocardial Infarction at a Young Age , 2003, Circulation.

[46]  M. Mukherjee,et al.  A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians , 2002, Clinical genetics.

[47]  Guangsen Zhang,et al.  Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. , 2001, Thrombosis research.

[48]  N. Wenger,et al.  Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans. , 2001, Thrombosis research.

[49]  N. Akar,et al.  Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction , 2001, Clinical cardiology.

[50]  G. Hallmans,et al.  Homozygosity for the C 677 →T mutation of 5,10‐methylenetetrahydrofolate reductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden , 2001, Coronary artery disease.

[51]  J. Joven,et al.  Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction. , 2000, Clinical biochemistry.

[52]  K. Kawazoe,et al.  Genetic polymorphism of 5,10‐methylenetetrahydrofolate increases risk of myocardial infarction and is correlated to elevated levels of homocysteine in the Japanese general population , 2000, Coronary artery disease.

[53]  M. Ruiz-Galdón,et al.  The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction. , 1999, Atherosclerosis.

[54]  M. Margaglione,et al.  Prothrombotic genetic risk factors in young survivors of myocardial infarction. , 1999, Blood.

[55]  A. Gardemann,et al.  The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease. , 1999, European heart journal.

[56]  L. Providência,et al.  The Mutation C677T in the Methylene Tetrahydrofolate Reductase Gene as a Risk Factor for Myocardial Infarction in the Portuguese Population , 1998, Thrombosis and Haemostasis.

[57]  E. Trabetti,et al.  Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. , 1998, Blood.

[58]  R. Abbate,et al.  The High Prevalence of Thermolabile 5-10 Methylenetetrahydrofolate Reductase (MTHFR) in Italians Is not Associated to an Increased Risk for Coronary Artery Disease (CAD) , 1998, Thrombosis and Haemostasis.

[59]  E. Trabetti,et al.  Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. , 1998, Blood.

[60]  J. Carlquist,et al.  A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. , 1997, Journal of the American College of Cardiology.

[61]  T. Raghunathan,et al.  Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. , 1997, Circulation.

[62]  A. Marian,et al.  A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. , 1997, Atherosclerosis.

[63]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.

[64]  J. Buring,et al.  Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. , 1996, Circulation.

[65]  N. Samani,et al.  Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. , 1996, QJM : monthly journal of the Association of Physicians.